Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells

Ewing sarcoma (EWS) is a challenging pediatric cancer characterized by vast intra-tumor heterogeneity. We evaluated the RNA-binding protein IGF2BP3, whose high expression correlates with a poor prognosis and an elevated tendency of metastases, as a possible soluble mediator of inter-cellular communi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer gene therapy 2023-09, Vol.30 (9), p.1285-1295
Hauptverfasser: Mancarella, Caterina, Giusti, Veronica, Caldoni, Giulia, Laginestra, Maria Antonella, Parra, Alessandro, Toracchio, Lisa, Giordano, Giorgia, Roncuzzi, Laura, Piazzi, Manuela, Blalock, William, Columbaro, Marta, De Feo, Alessandra, Scotlandi, Katia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1295
container_issue 9
container_start_page 1285
container_title Cancer gene therapy
container_volume 30
creator Mancarella, Caterina
Giusti, Veronica
Caldoni, Giulia
Laginestra, Maria Antonella
Parra, Alessandro
Toracchio, Lisa
Giordano, Giorgia
Roncuzzi, Laura
Piazzi, Manuela
Blalock, William
Columbaro, Marta
De Feo, Alessandra
Scotlandi, Katia
description Ewing sarcoma (EWS) is a challenging pediatric cancer characterized by vast intra-tumor heterogeneity. We evaluated the RNA-binding protein IGF2BP3, whose high expression correlates with a poor prognosis and an elevated tendency of metastases, as a possible soluble mediator of inter-cellular communication in EWS. Our data demonstrate that (i) IGF2BP3 is detected in cell supernatants, and it is released inside extracellular vesicles (EVs); (ii) EVs from IGF2BP3-positive or IGF2BP3-negative EWS cells reciprocally affect cell migration but not the proliferation of EWS recipient cells; (iii) EVs derived from IGF2BP3-silenced cells have a distinct miRNA cargo profile and inhibit the PI3K/Akt pathway in recipient cells; (iv) the 11 common differentially expressed miRNAs associated with IGF2BP3-positive and IGF2BP3-negative EVs correctly group IGF2BP3-positive and IGF2BP3-negative clinical tissue specimens. Overall, our data suggest that IGF2BP3 can participate in the modulation of phenotypic heterogeneity.
doi_str_mv 10.1038/s41417-023-00637-8
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10501906</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2829424580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-25a776924b0d4e2916213a751db2c0c21083b6875e9d465fb13c0b9ffe3f41693</originalsourceid><addsrcrecordid>eNp9kTtvFDEUhS0EIkvgD1AgSzQ0Q65f43GFkmiTrIhECqgtj8ez6zBrL_ZMQgr-ezxsCI-CysX9zvE99yD0msB7Aqw5ypxwIiugrAKomayaJ2hBuKwrIQCeogUoqiqigB2gFzlfA5ShZM_RAZNMMCGaBfqx_D4mY90wTINJ-MZlbwdXmZyj9WZ0HV6dn9GTK4bHKbiMl7c-rHE2ycatwbMOb_06mdHHgE3osOl7Z8eMr1bs49Hx1xHvzLi5NXfYBxycX2_amGaLWZpfome9GbJ79fAeoi9ny8-nF9Xlp_PV6fFlZbkUY0WFkbJWlLfQcUcVqSlhRgrStdSCpQQa1taNFE51vBZ9S5iFVpVNWM9Jrdgh-rD33U3t1nXWhRJ60Lvktybd6Wi8_nsS_Eav440mIKAcsC4O7x4cUvw2uTzqrc9zBhNcnLKmDVWcctFAQd_-g17HKYWSr1A1lyBUwwpF95RNMefk-sdtCOi5Xr2vV5d69c96dVNEb_7M8Sj51WcB2B7Iu_nKLv3--z-29_U-sLk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2864705983</pqid></control><display><type>article</type><title>Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells</title><source>SpringerLink Journals - AutoHoldings</source><creator>Mancarella, Caterina ; Giusti, Veronica ; Caldoni, Giulia ; Laginestra, Maria Antonella ; Parra, Alessandro ; Toracchio, Lisa ; Giordano, Giorgia ; Roncuzzi, Laura ; Piazzi, Manuela ; Blalock, William ; Columbaro, Marta ; De Feo, Alessandra ; Scotlandi, Katia</creator><creatorcontrib>Mancarella, Caterina ; Giusti, Veronica ; Caldoni, Giulia ; Laginestra, Maria Antonella ; Parra, Alessandro ; Toracchio, Lisa ; Giordano, Giorgia ; Roncuzzi, Laura ; Piazzi, Manuela ; Blalock, William ; Columbaro, Marta ; De Feo, Alessandra ; Scotlandi, Katia</creatorcontrib><description>Ewing sarcoma (EWS) is a challenging pediatric cancer characterized by vast intra-tumor heterogeneity. We evaluated the RNA-binding protein IGF2BP3, whose high expression correlates with a poor prognosis and an elevated tendency of metastases, as a possible soluble mediator of inter-cellular communication in EWS. Our data demonstrate that (i) IGF2BP3 is detected in cell supernatants, and it is released inside extracellular vesicles (EVs); (ii) EVs from IGF2BP3-positive or IGF2BP3-negative EWS cells reciprocally affect cell migration but not the proliferation of EWS recipient cells; (iii) EVs derived from IGF2BP3-silenced cells have a distinct miRNA cargo profile and inhibit the PI3K/Akt pathway in recipient cells; (iv) the 11 common differentially expressed miRNAs associated with IGF2BP3-positive and IGF2BP3-negative EVs correctly group IGF2BP3-positive and IGF2BP3-negative clinical tissue specimens. Overall, our data suggest that IGF2BP3 can participate in the modulation of phenotypic heterogeneity.</description><identifier>ISSN: 0929-1903</identifier><identifier>ISSN: 1476-5500</identifier><identifier>EISSN: 1476-5500</identifier><identifier>DOI: 10.1038/s41417-023-00637-8</identifier><identifier>PMID: 37353558</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>1-Phosphatidylinositol 3-kinase ; 13 ; 13/44 ; 13/95 ; 14/28 ; 14/34 ; 14/63 ; 38/61 ; 38/91 ; 631/67/1798 ; 692/699/67 ; 82/1 ; 82/80 ; AKT protein ; Biomedical and Life Sciences ; Biomedicine ; Cancer ; Cell adhesion &amp; migration ; Cell growth ; Cell interactions ; Cell migration ; Cell proliferation ; CRISPR ; DNA methylation ; Epigenetics ; Ewing's sarcoma ; Ewings sarcoma ; Extracellular vesicles ; Gene Expression ; Gene Therapy ; Metastases ; Metastasis ; MicroRNAs ; miRNA ; Nanoparticles ; Patients ; Pediatrics ; Proteins ; RNA-binding protein ; Tumors</subject><ispartof>Cancer gene therapy, 2023-09, Vol.30 (9), p.1285-1295</ispartof><rights>The Author(s) 2023</rights><rights>2023. The Author(s).</rights><rights>The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-25a776924b0d4e2916213a751db2c0c21083b6875e9d465fb13c0b9ffe3f41693</citedby><cites>FETCH-LOGICAL-c475t-25a776924b0d4e2916213a751db2c0c21083b6875e9d465fb13c0b9ffe3f41693</cites><orcidid>0000-0001-6105-721X ; 0000-0002-5778-4251 ; 0000-0001-6114-9499 ; 0000-0002-8045-4840 ; 0000-0002-9805-1361</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41417-023-00637-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41417-023-00637-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37353558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mancarella, Caterina</creatorcontrib><creatorcontrib>Giusti, Veronica</creatorcontrib><creatorcontrib>Caldoni, Giulia</creatorcontrib><creatorcontrib>Laginestra, Maria Antonella</creatorcontrib><creatorcontrib>Parra, Alessandro</creatorcontrib><creatorcontrib>Toracchio, Lisa</creatorcontrib><creatorcontrib>Giordano, Giorgia</creatorcontrib><creatorcontrib>Roncuzzi, Laura</creatorcontrib><creatorcontrib>Piazzi, Manuela</creatorcontrib><creatorcontrib>Blalock, William</creatorcontrib><creatorcontrib>Columbaro, Marta</creatorcontrib><creatorcontrib>De Feo, Alessandra</creatorcontrib><creatorcontrib>Scotlandi, Katia</creatorcontrib><title>Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells</title><title>Cancer gene therapy</title><addtitle>Cancer Gene Ther</addtitle><addtitle>Cancer Gene Ther</addtitle><description>Ewing sarcoma (EWS) is a challenging pediatric cancer characterized by vast intra-tumor heterogeneity. We evaluated the RNA-binding protein IGF2BP3, whose high expression correlates with a poor prognosis and an elevated tendency of metastases, as a possible soluble mediator of inter-cellular communication in EWS. Our data demonstrate that (i) IGF2BP3 is detected in cell supernatants, and it is released inside extracellular vesicles (EVs); (ii) EVs from IGF2BP3-positive or IGF2BP3-negative EWS cells reciprocally affect cell migration but not the proliferation of EWS recipient cells; (iii) EVs derived from IGF2BP3-silenced cells have a distinct miRNA cargo profile and inhibit the PI3K/Akt pathway in recipient cells; (iv) the 11 common differentially expressed miRNAs associated with IGF2BP3-positive and IGF2BP3-negative EVs correctly group IGF2BP3-positive and IGF2BP3-negative clinical tissue specimens. Overall, our data suggest that IGF2BP3 can participate in the modulation of phenotypic heterogeneity.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>13</subject><subject>13/44</subject><subject>13/95</subject><subject>14/28</subject><subject>14/34</subject><subject>14/63</subject><subject>38/61</subject><subject>38/91</subject><subject>631/67/1798</subject><subject>692/699/67</subject><subject>82/1</subject><subject>82/80</subject><subject>AKT protein</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer</subject><subject>Cell adhesion &amp; migration</subject><subject>Cell growth</subject><subject>Cell interactions</subject><subject>Cell migration</subject><subject>Cell proliferation</subject><subject>CRISPR</subject><subject>DNA methylation</subject><subject>Epigenetics</subject><subject>Ewing's sarcoma</subject><subject>Ewings sarcoma</subject><subject>Extracellular vesicles</subject><subject>Gene Expression</subject><subject>Gene Therapy</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>MicroRNAs</subject><subject>miRNA</subject><subject>Nanoparticles</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Proteins</subject><subject>RNA-binding protein</subject><subject>Tumors</subject><issn>0929-1903</issn><issn>1476-5500</issn><issn>1476-5500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kTtvFDEUhS0EIkvgD1AgSzQ0Q65f43GFkmiTrIhECqgtj8ez6zBrL_ZMQgr-ezxsCI-CysX9zvE99yD0msB7Aqw5ypxwIiugrAKomayaJ2hBuKwrIQCeogUoqiqigB2gFzlfA5ShZM_RAZNMMCGaBfqx_D4mY90wTINJ-MZlbwdXmZyj9WZ0HV6dn9GTK4bHKbiMl7c-rHE2ycatwbMOb_06mdHHgE3osOl7Z8eMr1bs49Hx1xHvzLi5NXfYBxycX2_amGaLWZpfome9GbJ79fAeoi9ny8-nF9Xlp_PV6fFlZbkUY0WFkbJWlLfQcUcVqSlhRgrStdSCpQQa1taNFE51vBZ9S5iFVpVNWM9Jrdgh-rD33U3t1nXWhRJ60Lvktybd6Wi8_nsS_Eav440mIKAcsC4O7x4cUvw2uTzqrc9zBhNcnLKmDVWcctFAQd_-g17HKYWSr1A1lyBUwwpF95RNMefk-sdtCOi5Xr2vV5d69c96dVNEb_7M8Sj51WcB2B7Iu_nKLv3--z-29_U-sLk</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Mancarella, Caterina</creator><creator>Giusti, Veronica</creator><creator>Caldoni, Giulia</creator><creator>Laginestra, Maria Antonella</creator><creator>Parra, Alessandro</creator><creator>Toracchio, Lisa</creator><creator>Giordano, Giorgia</creator><creator>Roncuzzi, Laura</creator><creator>Piazzi, Manuela</creator><creator>Blalock, William</creator><creator>Columbaro, Marta</creator><creator>De Feo, Alessandra</creator><creator>Scotlandi, Katia</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6105-721X</orcidid><orcidid>https://orcid.org/0000-0002-5778-4251</orcidid><orcidid>https://orcid.org/0000-0001-6114-9499</orcidid><orcidid>https://orcid.org/0000-0002-8045-4840</orcidid><orcidid>https://orcid.org/0000-0002-9805-1361</orcidid></search><sort><creationdate>20230901</creationdate><title>Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells</title><author>Mancarella, Caterina ; Giusti, Veronica ; Caldoni, Giulia ; Laginestra, Maria Antonella ; Parra, Alessandro ; Toracchio, Lisa ; Giordano, Giorgia ; Roncuzzi, Laura ; Piazzi, Manuela ; Blalock, William ; Columbaro, Marta ; De Feo, Alessandra ; Scotlandi, Katia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-25a776924b0d4e2916213a751db2c0c21083b6875e9d465fb13c0b9ffe3f41693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>13</topic><topic>13/44</topic><topic>13/95</topic><topic>14/28</topic><topic>14/34</topic><topic>14/63</topic><topic>38/61</topic><topic>38/91</topic><topic>631/67/1798</topic><topic>692/699/67</topic><topic>82/1</topic><topic>82/80</topic><topic>AKT protein</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer</topic><topic>Cell adhesion &amp; migration</topic><topic>Cell growth</topic><topic>Cell interactions</topic><topic>Cell migration</topic><topic>Cell proliferation</topic><topic>CRISPR</topic><topic>DNA methylation</topic><topic>Epigenetics</topic><topic>Ewing's sarcoma</topic><topic>Ewings sarcoma</topic><topic>Extracellular vesicles</topic><topic>Gene Expression</topic><topic>Gene Therapy</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>MicroRNAs</topic><topic>miRNA</topic><topic>Nanoparticles</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Proteins</topic><topic>RNA-binding protein</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mancarella, Caterina</creatorcontrib><creatorcontrib>Giusti, Veronica</creatorcontrib><creatorcontrib>Caldoni, Giulia</creatorcontrib><creatorcontrib>Laginestra, Maria Antonella</creatorcontrib><creatorcontrib>Parra, Alessandro</creatorcontrib><creatorcontrib>Toracchio, Lisa</creatorcontrib><creatorcontrib>Giordano, Giorgia</creatorcontrib><creatorcontrib>Roncuzzi, Laura</creatorcontrib><creatorcontrib>Piazzi, Manuela</creatorcontrib><creatorcontrib>Blalock, William</creatorcontrib><creatorcontrib>Columbaro, Marta</creatorcontrib><creatorcontrib>De Feo, Alessandra</creatorcontrib><creatorcontrib>Scotlandi, Katia</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mancarella, Caterina</au><au>Giusti, Veronica</au><au>Caldoni, Giulia</au><au>Laginestra, Maria Antonella</au><au>Parra, Alessandro</au><au>Toracchio, Lisa</au><au>Giordano, Giorgia</au><au>Roncuzzi, Laura</au><au>Piazzi, Manuela</au><au>Blalock, William</au><au>Columbaro, Marta</au><au>De Feo, Alessandra</au><au>Scotlandi, Katia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells</atitle><jtitle>Cancer gene therapy</jtitle><stitle>Cancer Gene Ther</stitle><addtitle>Cancer Gene Ther</addtitle><date>2023-09-01</date><risdate>2023</risdate><volume>30</volume><issue>9</issue><spage>1285</spage><epage>1295</epage><pages>1285-1295</pages><issn>0929-1903</issn><issn>1476-5500</issn><eissn>1476-5500</eissn><abstract>Ewing sarcoma (EWS) is a challenging pediatric cancer characterized by vast intra-tumor heterogeneity. We evaluated the RNA-binding protein IGF2BP3, whose high expression correlates with a poor prognosis and an elevated tendency of metastases, as a possible soluble mediator of inter-cellular communication in EWS. Our data demonstrate that (i) IGF2BP3 is detected in cell supernatants, and it is released inside extracellular vesicles (EVs); (ii) EVs from IGF2BP3-positive or IGF2BP3-negative EWS cells reciprocally affect cell migration but not the proliferation of EWS recipient cells; (iii) EVs derived from IGF2BP3-silenced cells have a distinct miRNA cargo profile and inhibit the PI3K/Akt pathway in recipient cells; (iv) the 11 common differentially expressed miRNAs associated with IGF2BP3-positive and IGF2BP3-negative EVs correctly group IGF2BP3-positive and IGF2BP3-negative clinical tissue specimens. Overall, our data suggest that IGF2BP3 can participate in the modulation of phenotypic heterogeneity.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>37353558</pmid><doi>10.1038/s41417-023-00637-8</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-6105-721X</orcidid><orcidid>https://orcid.org/0000-0002-5778-4251</orcidid><orcidid>https://orcid.org/0000-0001-6114-9499</orcidid><orcidid>https://orcid.org/0000-0002-8045-4840</orcidid><orcidid>https://orcid.org/0000-0002-9805-1361</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0929-1903
ispartof Cancer gene therapy, 2023-09, Vol.30 (9), p.1285-1295
issn 0929-1903
1476-5500
1476-5500
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10501906
source SpringerLink Journals - AutoHoldings
subjects 1-Phosphatidylinositol 3-kinase
13
13/44
13/95
14/28
14/34
14/63
38/61
38/91
631/67/1798
692/699/67
82/1
82/80
AKT protein
Biomedical and Life Sciences
Biomedicine
Cancer
Cell adhesion & migration
Cell growth
Cell interactions
Cell migration
Cell proliferation
CRISPR
DNA methylation
Epigenetics
Ewing's sarcoma
Ewings sarcoma
Extracellular vesicles
Gene Expression
Gene Therapy
Metastases
Metastasis
MicroRNAs
miRNA
Nanoparticles
Patients
Pediatrics
Proteins
RNA-binding protein
Tumors
title Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T04%3A04%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracellular%20vesicle-associated%20IGF2BP3%20tunes%20Ewing%20sarcoma%20cell%20migration%20and%20affects%20PI3K/Akt%20pathway%20in%20neighboring%20cells&rft.jtitle=Cancer%20gene%20therapy&rft.au=Mancarella,%20Caterina&rft.date=2023-09-01&rft.volume=30&rft.issue=9&rft.spage=1285&rft.epage=1295&rft.pages=1285-1295&rft.issn=0929-1903&rft.eissn=1476-5500&rft_id=info:doi/10.1038/s41417-023-00637-8&rft_dat=%3Cproquest_pubme%3E2829424580%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2864705983&rft_id=info:pmid/37353558&rfr_iscdi=true